Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 11/20 | 0.55 |
| ▸ | ESR2 | Q92731 | 10/20 | 0.55 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.45 |
| ▸ | SHBG | P04278 | 2/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | PRKCI | P41743 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | STS | P08842 | 2/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.40 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | SERPINA6 | P08185 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30835166 | 1.00 | ESR1 (0.55) | ESR1ESR2HSD17B1SHBGSIGMAR1 | |
| SCHEMBL16527048 | 0.95 | ESR1 (0.58) | ESR1ESR2HSD17B1SHBGSIGMAR1 | |
| SCHEMBL13049833 | 0.89 | ESR1 (0.53) | ESR1ESR2HSD17B1SHBGCYP19A1 | |
| SCHEMBL8034552 | 0.89 | ESR1 (0.53) | ESR1ESR2HSD17B1SHBGCYP19A1 | |
| SCHEMBL4981817 | 0.85 | ESR1 (0.46) | ESR1ESR2CYP19A1MAOAMAOB | |
| SCHEMBL15577013 | 0.81 | HTR2C (0.58) | ESR1ESR2SLC6A4HTR2BTSHR | |
| SCHEMBL19302170 | 0.81 | HTR2C (0.58) | ESR1ESR2SLC6A4HTR2BTSHR | |
| SCHEMBL18468830 | 0.81 | HTR2C (0.58) | ESR1ESR2SLC6A4HTR2BTSHR | |
| SCHEMBL7913405 | 0.79 | ESR2 (0.57) | ESR1ESR2HSD17B1SHBGSIGMAR1 | |
| SCHEMBL6902991 | 0.79 | SRD5A1 (0.42) | ESR1ESR2LMNASLC6A4HTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4695262-A1 | PYRIDO[4,3-D]PYRIMIDINE COMPOUNDS | Pfizer Inc. (US) | 2026-02-18 | — | — | EP | disclosed |
| US-12466803-B2 | BCKDK inhibitors and/or degraders | PFIZER INC. (US) | 2025-11-11 | — | — | US | disclosed |
| WO-2024213979-A1 | PYRIDO[4,3-D]PYRIMIDINE COMPOUNDS | PFIZER INC. (US) | 2024-10-17 | — | — | WO | disclosed |
| WO-2024125600-A1 | HETEROCYCLIC COMPOUNDS ACTING AS KRAS INHIBITORS, PREPARATION THEREFOR AND THERAPEUTIC USE THEREOF | 上海科州药物研发有限公司 | 2024-06-20 | — | — | WO | disclosed |
| WO-2023100061-A1 | 3-PHENYL-1-BENZOTHIOPHENE-2-CARBOXYLIC ACID DERIVATIVES AS BRANCHED-CHAIN ALPHA KETO ACID DEHYDROGENASE KINASE INHIBITORS FOR THE TREATMENT OF DIABETES, KIDNEY DISEASES, NASH AND HEART FAILURE | PFIZER INC. (US) | 2023-06-08 | — | — | WO | disclosed |
| US-20230167080-A1 | BCKDK INHIBITORS AND/OR DEGRADERS | PFIZER INC. (US) | 2023-06-01 | — | — | US | disclosed |
| WO-2022247760-A1 | HETEROCYCLIC COMPOUNDS AS KRAS INHIBITOR, AND PREPARATION THEREFOR AND USE THEREOF IN TREATMENT | 上海科州药物研发有限公司 | 2022-12-01 | — | — | WO | disclosed |
| WO-2015025962-A1 | AMIDINE COMPOUND OR SALT THEREOF | 富山化学工業株式会社 (JP) | 2015-02-26 | — | — | WO | disclosed |
| US-7985519-B2 | Aromatic polycarbonate, electrophotographic photoreceptor, and image forming apparatus | SHARP KABUSHIKI KAISHA (JP) | 2011-07-26 | — | — | US | disclosed |
| US-7985519-B2 | Aromatic polycarbonate, electrophotographic photoreceptor, and image forming apparatus | SHARP KABUSHIKI KAISHA (JP) | 2011-07-26 | — | — | US | disclosed |
| US-20080199215-A1 | AROMATIC POLYCARBONATE, ELECTROPHOTOGRAPHIC PHOTORECEPTOR, AND IMAGE FORMING APPARATUS | SHARP KABUSHIKI KAISHA (JP) | 2008-08-21 | — | — | US | disclosed |
| US-20080199215-A1 | AROMATIC POLYCARBONATE, ELECTROPHOTOGRAPHIC PHOTORECEPTOR, AND IMAGE FORMING APPARATUS | SHARP KABUSHIKI KAISHA (JP) | 2008-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12466803-B2 | BCKDK inhibitors and/or degraders | BCKDK, KHK, PDK4 | ESR1 2725/4885ESR2 2617/4885HSD17B1 75/4885 |
| US-20230167080-A1 | BCKDK INHIBITORS AND/OR DEGRADERS | BCKDK, KHK, PDK4 | ESR1 2725/4885ESR2 2617/4885HSD17B1 75/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.